Belpointe Asset Management LLC Repligen Corp Transaction History

Belpointe Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$170.78 - $208.42 $304,329 - $371,404	1,782 New	1,782 $327,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $21,287 - $27,337	138 Added 27.17%	646 $108,000
Q4 2022 Feb 08, 2023	SELL	$162.42 - $220.56 $60,745 - $82,489	-374 Reduced 42.4%	508 $86,000
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $69,943 - $111,707	-436 Reduced 33.08%	882 $165,000
Q2 2022 Aug 02, 2022	BUY	$140.68 - $188.02 $85,674 - $114,504	609 Added 85.9%	1,318 $214,000
Q1 2022 Apr 28, 2022	BUY	$161.19 - $257.96 $40,458 - $64,747	251 Added 54.8%	709 $133,000
Q4 2021 Feb 15, 2022	SELL	$247.59 - $304.47 $23,768 - $29,229	-96 Reduced 17.33%	458 $121,000
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $107,902 - $179,612	554 New	554 $160,000
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $353,525 - $443,469	-1,960 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $290,236 - $404,877	1,960 New	1,960 $376,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.